https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/pj0b5iux/1025-omd-cover-image.png
Ophthalmology Management
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/43vf3gam/cover_oct25_web.jpg
Retinal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/0s0ksauu/0925-gp-cover.jpg
Glaucoma Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/0jsmmz3o/op_1025_cover_final.jpg
Ophthalmic Professional
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/jdnlmuh3/1025-oasc-cover-final.jpg
The Ophthalmic ASC
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/aqbjxwjw/pp-cover.jpg
Presbyopia Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/npjdtl1w/cp_november_cover.jpg
Corneal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.glaucomaphysician.net/media/mvqdq2hc/nrp_cover_october_2024.jpg
New Retinal Physician
An overview of the technology and its clinical applications, including case study examples
By Davinder S. Grover, MD, MPH
A safe, well-tolerated MIGS device with the advantages of bypassing to the subconjunctiva
By Robert J. Noecker, MD, MBA
A supraciliary MIGS device lowers IOP in a procedure concurrent with cataract surgery
By Steven R. Sarkisian, Jr., MD
Alternative therapies are available and more are on the horizon. But are patients and physicians ready to move away from drops?
By Nathan M. Radcliffe, MD
Rapidly evolving landscape for MIGS
By Kevin J. Corcoran, COE, FNAO
How to adapt this technology for the management of glaucoma patients
By Igor Bussel, MD, MS, MHA
Glaukos' continued focus on transforming glaucoma therapy
By Dana M. Hornbeak, MD, MPH
The intriguing potential of a new drug with two mechanisms of action to provide a more effective first-line therapy
By Inder Paul Singh, MD